申请人:Osaka University
公开号:EP2617720A1
公开(公告)日:2013-07-24
A compound represented by the general formula (M):
(wherein R1 represents a substituted or unsubstituted aromatic heterocyclic group,
R2 represents a hydrogen atom, a substituted or unsubstituted alkyl group having 1 to 3 carbon atoms, OR3, N(R3)2, C(=O)OR3 or C(=O)N(R3)2,
R3 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or an acyl group having 1 to 4 carbon atoms,
R4 represents a hydrogen atom, an oxygen atom or OR5, and
R5 represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or an acyl group having 1 to 3 carbon atoms); or
a pharmaceutically acceptable salt thereof is a cortistatin A analog which is useful as an active ingredient of medicaments for cancer prevention or treatment in that the analog can be mass-produced by chemical synthesis due to its simple chemical structure and retains the same biological activities as those of cortistatin A.
通式(M)代表的化合物:
(其中 R1 代表取代或未取代的芳香杂环基团、
R2 代表氢原子、具有 1 至 3 个碳原子的取代或未取代的烷基、OR3、N(R3)2、C(=O)OR3 或 C(=O)N(R3)2
R3 代表氢原子、具有 1 至 4 个碳原子的烷基或具有 1 至 4 个碳原子的酰基、
R4 代表氢原子、氧原子或 OR5,以及
R5 代表氢原子、具有 1 至 3 个碳原子的烷基或具有 1 至 3 个碳原子的酰基);或
其药学上可接受的盐是可的松素 A 类似物,可作为预防或治疗癌症药物的活性成分,因为该类似物的化学结构简单,可通过化学合成大规模生产,并保留了与可的松素 A 相同的生物活性。